← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 17, 2019Last known activity
Jun 19, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 4 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT05623605Reponsible party - principal investigatorPhase 4Jun 19, 2022
- NCT05623605Lead sponsorPhase 4Jun 19, 2022
- NCT05623605Sponsor investigatorPhase 4Jun 19, 2022
- NCT05517187Lead sponsorN/AMar 10, 2022
- NCT05517187Reponsible party - principal investigatorN/AMar 10, 2022
- NCT05861297Reponsible party - principal investigatorPhase 4May 5, 2020
- NCT05861297Lead sponsorPhase 4May 5, 2020
- NCT04169698CollaboratorPhase 2/Phase 3Oct 17, 2019
Details
- Last known activity
- Jun 19, 2022